A report released last week by the The Institute for Safe Medication Practices (and covered yesterday on PharmExec.com), listed Pfizer’s smoking cessation drug Chantix as the number one most reported drug for adverse reactions in the first quarter of 2008.
The report states that FDA received 1,001 reports of serious side effects for varenicline (the generic [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Pfizer Responds to Adverse Events Report